Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d’Etude des Tumeurs Endocrines (GTE) and the E

Julien Hadoux, Christina Kanaan, Alice Durand, Ségolène Hescot, Vincent Hautefeuille, Guillaume Cadiot, Igor Tauveron, Sandrine Laboureau, Christine Do Cao, Thomas Walter, Caroline Petorin, Odile Blanchet, Arnaud Jannin, Céline Gu, Matthieu Faron, Emmanuelle Leteurtre, Marie-Christine Rousselet, Juliette J. Zakeyh, Aude Marchal, Denis Chatelain, Clément Beaulaton, Valérie Hervieu, Michel Ducreux, Jean-Yves Scoazec, Eric Baudin